StockNews.com Initiates Coverage on ARCA biopharma (NASDAQ:ABIO)

StockNews.com initiated coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Price Performance Shares of ABIO stock opened at $1.75 on Thursday. The firm has a market cap of $25.22 million, a PE ratio […]

Leave a Reply

Your email address will not be published.

Previous post Brainstorm Cell Therapeutics (NASDAQ:BCLI) Research Coverage Started at StockNews.com
Next post Phoenix New Media (NYSE:FENG) Now Covered by Analysts at StockNews.com